Mounjaro in Coventry: the facts that actually matter

The myth: you need a local clinic or GP referral to get Mounjaro privately

This is the misunderstanding our prescribers encounter most often from people in Coventry. Many assume that private weight-loss treatment means booking an in-person appointment at a specialist clinic, or that their GP must refer them before anything can happen. Neither is true for the private route.

A GPhC-registered online pharmacy can conduct the entire process legally and safely without you leaving your home. Consultation is completed online; a clinician reviews it the same day; identity and weight are verified before any prescription is issued; and the medicine arrives in plain, unbranded packaging. For anyone in Coventry ordering before 12 pm on a working day, same-day dispatch is the target once clinical approval is confirmed, handy if payday has just landed or you've been putting it off since the weekend.

What you do need, regardless of how you access treatment, is a genuine clinical assessment. A prescriber reviews your health history, current medications and BMI. That step is non-negotiable, and any seller skipping it is operating outside the law. The full Mounjaro overview explains what that assessment covers and what to expect from the process.

Who actually qualifies, and what the prescriber weighs up

The licensed eligibility criteria for Mounjaro in weight management are set by the medicine's Summary of Product Characteristics: adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, prediabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance.

Those numbers are a starting point, not a guarantee. The prescriber looks at the whole picture: your medical history, any medicines you already take, contraindications, and whether the benefit genuinely outweighs the risk for you as an individual. If you're uncertain whether you'd qualify, the should I try Mounjaro page works through the decision in detail.

For context on what NHS access currently looks like in England (which has strict, phased eligibility criteria quite separate from the private route) the NICE tirzepatide guidance (TA1026) sets out the qualifying conditions and BMI thresholds the NHS uses. Private eligibility is governed by the SmPC, not those NHS thresholds, so the two routes are not identical.

Side effects: the honest picture for Coventry patients starting treatment

Mounjaro's most common side effects are gastrointestinal. Nausea is the one people mention most; loose stools, constipation, reflux and burping also appear, particularly in the first few weeks or after a dose step up. Fatigue and mild headaches are reported less frequently. For most people these effects are manageable and ease as the body adjusts, though they vary considerably from person to person.

A small number of people experience more serious reactions. Acute pancreatitis is rare but recognised, in January 2026 the MHRA issued a Drug Safety Update on this, advising that severe stomach pain radiating to the back, with or without vomiting, warrants urgent medical attention. If you develop those symptoms, stop the injection and call 111 or go to A&E. The MHRA Yellow Card scheme lets patients report any suspected side effect directly, which contributes to ongoing safety monitoring.

The NHS patient-level information on tirzepatide on the NHS website is worth reading before you start. It covers what to watch for, when to seek help, and which existing conditions need particular attention from your prescriber. That information doesn't replace the Patient Information Leaflet inside your pen, but it's a clear, accessible summary. You can also look at the frequently asked questions on our site for practical guidance on what to do if a side effect concerns you, including if you have questions about how Mounjaro and Covid interact, which is something a number of patients starting treatment have asked about.

Cost and supply: what private treatment in Coventry actually involves

Private Mounjaro pricing reflects the dose and the provider. Since Eli Lilly revised its UK list prices in September 2025 (the highest-dose pen's list price moved from around £122 to around £330 per four-week pen) private market prices have ranged roughly £149 to £375 per month depending on dose and supplier. Those are market figures, reported widely at the time; they are not a quote from any specific service.

What varies more than the headline price is what it actually includes. Some providers add consultation fees, prescription fees, or delivery charges on top. The Mounjaro cost breakdown page looks at this in more detail, including what to check before committing to a provider, and if you are also wondering whether you can offset some of that cost it is worth reading about insurance that covers Mounjaro, as the picture is more nuanced than many people expect. At nume, one price covers the consultation, prescription, treatment and next-working-day tracked delivery, no subscription, and every repeat order is reviewed clinically before dispatch.

Supply reliability is worth asking about too. Mounjaro is manufactured by Eli Lilly and sourced through the licensed UK supply chain; if you want to understand more about how and where it is produced, the Mounjaro manufacturing page covers that. Legitimate supply through a GPhC-registered pharmacy is the only route that guarantees you're receiving the genuine medicine, the MHRA has seized large quantities of fake tirzepatide pens sold through unofficial channels, some containing dangerous substitutes. Verifying any online pharmacy on the GPhC register takes about thirty seconds and is the simplest safety check available.